DexCare Stock

Healthcare technology platform that streamlines patient access and care delivery through AI-powered solutions and data integration.

Buy

Buy DexCare shares

Sign up to view historical trading trends and place an offer.

Sell

Sell DexCare shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

DexCare is a healthcare technology company that enhances the patient care experience by integrating advanced data and artificial intelligence. It focuses on streamlining patient access to healthcare services, improving clinical decision-making, and enabling healthcare providers to deliver more efficient care. The company’s platform allows for seamless coordination and personalized healthcare delivery.

Sector

Healthcare & Life Sciences

Founded

2020

Headquarters

Seattle, WA

Buy

Buy DexCare shares

Sign up to view historical trading trends and place an offer.

Sell

Sell DexCare shares

Understand share pricing, list anonymously, and benefit from transparent fees.

DexCare Management Team

DexCare people and management

  • Board Member
    Delos M Cosgrove
  • Chief Innovation Officer
    Chris Carruthers
  • Board Member
    Caroline Xie
  • Board Member
    Todd Cozzens
  • Founder, Chief Commercial Officer
    Sean O'Connor
  • Founder, CEO
    Derek Streat
  • Chief Marketing Officer
    Jamie Gier
  • Chief Product Officer
    Mike Lewis
  • Board Member
    David Kereiakes
  • Board Member
    Lynne O'Keefe
  • Chief People Officer
    Robin Borg

DexCare Valuations & Financials

Gain Insights Into DexCare Stock Valuation & Share Prices

View real-time NPM data on DexCare stock including daily DexCare stock price estimates, valuation history, and historical share price information. Access DexCare financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track DexCare pricing across six independent market signals. Looking for private company due diligence data sources on DexCare? Get in touch to learn more.

Similar Companies

Explore companies

like DexCare

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Droplet Biosciences

    Healthcare & Life Sciences

    Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.

  • Lyra Healthcare-Logo

    Lyra

    Healthcare & Life Sciences

    Digital health startup using technology to connect companies and employees to mental health providers.

  • Hinge Health-Logo

    Hinge Health

    Healthcare & Life Sciences

    Digital clinic for back, joint, and muscle pain.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • Curology-Logo

    Curology

    Healthcare & Life Sciences

    Offers personalized prescription skin care medications delivered directly to you.

  • Color-Logo

    Color

    Healthcare & Life Sciences

    Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

  • Cityblock Health-Logo

    Cityblock

    Healthcare & Life Sciences

    Tech-driven care provider for communities with complex needs.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

FAQ

Questions?

We have answers

Buy DexCare Stock

DexCare stock does not trade on public stock exchanges. DexCare stock is considered a private security and you need to be an accredited investor to trade shares. To invest in DexCare stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell DexCare Stock

DexCare Stock does not trade on public stock exchanges. In order to sell DexCare shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

DexCare Stock Price

DexCare does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view DexCare share price and other valuable private market data.

Read more about secondary market private company stock prices:

DexCare Stock Ticker Symbol

There is no ticker symbol for DexCare stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell DexCare Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell DexCare stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in DexCare Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in DexCare stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

DexCare Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

DexCare IPO

DexCare is a private company and has not had an IPO. There is currently no DexCare IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to DexCare IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.